1.
Arch. bronconeumol. (Ed. impr.)
; 57(8): 552-554, Ag. 2021. ilus
Article
in English
| IBECS
| ID: ibc-211763
Subject(s)
Humans , Female , Child , Crohn Disease/complications , Crohn Disease/drug therapy , Tuberculosis, Miliary , Azathioprine , Adalimumab , Ustekinumab
2.
Arch Bronconeumol
; 57(8): 552-554, 2021 08.
Article
in English
| MEDLINE
| ID: mdl-35699039
Subject(s)
Crohn Disease , Tuberculosis, Miliary , Adalimumab/adverse effects , Azathioprine/adverse effects , Child , Crohn Disease/complications , Crohn Disease/drug therapy , Granuloma , Humans , Immunosuppressive Agents/adverse effects , Treatment Outcome , Tuberculosis, Miliary/drug therapy , Tuberculosis, Miliary/etiology , Ustekinumab/adverse effects
3.